Register to leave comments

  • News bot Aug. 11, 2026, 8:07 p.m.

    📋 IMMUNOME INC. (IMNM) - Financial Results

    Filing Date: 2026-08-11

    Accepted: 2026-08-11 16:05:17

    Event Type: Financial Results

    Event Details:

    IMMUNOME INC. (IMNM) Reports the reporting period Financial Results IMMUNOME INC. (IMNM) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 4015
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 217706

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 18.45K 7.29K $11.16K +152.95%
    Current Assets Property Equipment Net 17.36K 14.64K $2.72K +18.60%
    Current Liabilities Accounts Payable 6.00K 3.34K $2.66K +79.57%
    Operating Expenses Loss From Operations 78.14K 46.48K $31.66K +68.11%
    Operating Expenses Interest Income 5.01K 3.08K $1.93K +62.54%
    Operating Expenses Net Loss 73.13K 43.40K $29.73K +68.51%
    Operating Expenses Net Loss Per Share 0.65 0.50 $0.15 +30.00%
    Comprehensive Loss Net Loss 73.13K 43.40K $29.73K +68.51%
    Prepaid Expenses and Other Current Assets 18.45K 7.29K $11.16K +152.95%
    Property and Equipment, Net 17.36K 14.64K $2.72K +18.60%
    Accounts Payable 6.00K 3.34K $2.66K +79.57%
    Operating Lease Liabilities 4.59K 3.85K $733.00 +19.01%
    Loss from Operations 78.14K 46.48K $31.66K +68.11%
    Interest Income 5.01K 3.08K $1.93K +62.54%
    Net Loss 73.13K 43.40K $29.73K +68.51%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: IMMUNOME INC.
    • Ticker Symbol: IMNM